Clinical trials, agri-biotech and bio-fuels are becoming opportunities. There are a lot of growth drivers and trigger points which, she said, will deliver in the next five years.
Kiran Mazumdar-Shaw, chairman and managing director of Biocon, Chanda Kochar, executive director of ICICI Bank and Vidya Chhabria, chairman of Jumbo Group
Singh, who opened up the economy as finance minister and served as prime minister for two consecutive terms, died on Thursday at the age of 92. "History will forever honour his pivotal role in the transformative 1991 reforms that reshaped India and opened its doors to the world.
Biocon, India's top biotech company, is looking to go in for listing of its stocks overseas in two years time, said its chairman and managing director Kiran Mazumdar-Shaw.
The Bengaluru-based firm has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialisation of generic versions of its three insulin analog products, Biocon Ltd said in a statement.
Taking a break from their hectic schedule and boardroom meetings, nine CEOs would display their singing prowess at a charity dinner event in Bengaluru to raise funds for children on July 16.
Reliance Industries Chairman Mukesh Ambani retains the title of India's richest man with personal assets of $18.9 billion.
The company has launched the product in 10ml and 3ml vials, Biocon said.
ICICI Bank CEO and MD Chanda Kochchar, Biocon founder Kiran Mazumdar-Shaw and film producer Ekta Kapoor are among the nine Indian women named in Forbes magazine's inaugural 'Asia Power Businesswomen list'.
Industry must take strong collective action to protect the reputation it enjoys in global markets, says Kiran Mazumdar Shaw.
Other corporate leaders, including Biocon chief Kiran Mazumdar Shaw, UB Group Chairman Vijay Mallya and Mahindra Group vice-chairman Anand Mahindra, have also expressed concerns over the current state of economy in the country.
Nine Indians, including Prime Minister Manmohan Singh, cricket legend Sachin Tendulkar and economist Amartya Sen have been named in Time magazine's annual list of 100 most influential people.
India's biotechnology industry is pushing the government for fiscal incentives, import duty exemption and correction of policy that gives MNCs higher drug prices than "desi" producers, ahead of the Union budget.
Industry leaders have urged the government to carry forward the reforms process.
Every year, BioSingapore receives nominations from biotechnology industry associations, industry peers, academics and institutions across Asia-Pacific for the most outstanding companies or individuals in various categories. The nominees are judged by a panel of distinguished leaders in the field.
In this second part - of 'Glass-ceiling in India' - we bring you India's successful entrepreneurs. These women are stereotype-busters in their own right.
Fourth edition of TiE Chennai's TiECON, Chennai 2011 will be held on November 24.
Bt brinjal is a genetically-modified vegetable which is infused with Cry1Ac gene from a bacterium Bacillus thuringiensis to make the plant resistant to the fruit and shoot borers and certain pests.
Three Indians PepsiCo chief Indra Nooyi, ICICI Bank's CEO Chanda Kocchar and Kiran Mazumdar Shaw of Biocon -- have been listed in 'The World's 100 Most Powerful Women' list by Forbes magazine.
A video of a doctor, caught in Bengaluru's notorious traffic and running to hospital to perform a surgery after abandoning his car midway, has gone viral on social media.
Biocon was scouting for more strategic alliances and exploring opportunities for outlicensing its biotech drugs under development, as it pitches for a slot among the top three bio-pharmaceutical players across the globe, said Kiran Mazumdar-Shaw, chairman and managing director.
Researchers and scientists in India would have to be innovative if the country wished to unleash its vast intellectual potential, chairman and managing director of Biocon Ltd Kiran Mazumdar Shaw said on Saturday.
Union Finance Minister P Chidambaram regretted that there has been stiff resistance from certain quarters over the reservation bill, which would ensure 33 per cent seats for women in Parliament and legislatures. Chidambaram said this while releasing the book Karmic Divas -- stories of eight powerful and wealthy women written by Prerna Kaul Misra and printed by Vitasta publications.
The Biocon chairman said there is a regulatory path for GM crops which aims to establish safety and efficacy over an accepted period and it has been diligently followed by Bt brinjal on the basis of which the Genetic Engineering Approval Committee has given its positive verdict.
Chaitanya Sagar Bethu (ISB Class of 2010) shares his experience of spending the day with Narayana Murthy, Infosys chief mentor.
Biotechnology major Biocon has got the Drug and Controller General of India approval for marketing its BIOMAb EGFR in the Indian market. This is a proprietary product of Biocon, which will be used in treating head and neck cancers.
"We will continue to hire people as our growing business demands manpower," CMD Kiran Mazumdar Shaw told reporters while announcing the company's half-yearly results.
Nobex, after running out of money last year, had filed for bankruptcy.
Blaming it on the "ineffective" bureaucracy and "very confused" ruling coalition in Karnataka, Kiran Mazumdar-Shaw, managing director of Biocon Ltd on Friday said infrastructural woes were impeding the growth of Bangalore.
"My view on taxation levels in India is that it is at a reasonable level and I think what is more important is how the government uses taxpayers' money," said Kiran Mazumdar-Shaw, the Chairman and Managing Director of Biocon, India's largest biotech company by revenue, said.
The Indian biotech sector continues to face an acute shortage of specialists. But now there is a ray of hope, interestingly from a dark story being narrated in the pharma and biotech sectors in the United States and Europe. The sector is seeing downsizing there. This has made scientists of Indian origin explore opportunities in India. "The shortage and the noticeable gap is in terms of discovery-led drug development," said Kiran Mazumdar Shaw, CMD, Biocon
Biotechnology major Biocon on Tuesday said it aims to achieve revenues of $1 billion in the next three years.
Ajay Lakhotia, an ISB student, shares his experience of spending the day with former managing director and CEO of ICICI Bank KV Kamath and the management lessons that this young MBA grad has learnt from the banking veteran.
As Shah Rukh Khan and Yusuf Arakkal and Rana Dasgupta and Kiran Mazumdar Shaw stand for the best of us, there is too much in daily life that showcases us at our apathetic, or misguided, worst, says Sheba Thayil in this Independence Day column.
Biocon Ltd ill seek Drug Controller General of India's approval for its novel monoclonal antibody indicated towards the treatment of head and neck cancer, Biomab EGFR.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances